PROCEPT BioRobotics (PRCT) Earnings Report Date & History

Check the next PRCT earnings date, EPS forecasts, and historical earnings-related price changes

PRCT Earnings Report

PROCEPT BioRobotics reported earnings of -$ 0.46 per PRCT share on Nov 4, 2026, beating analysts' expectations by 17.49%.Meanwhile, the company posted an EPS of -$ 0.43 during the same period last year, marking a -16.18% change.

Report Date Nov 4, 2026
Forecasted EPS -$ 0.39
Earnings Per Share (Surprise) -$ 0.46   (-$ 0.07)
Last Year's EPS -$ 0.43
EPS YoY Change -16.18%

PROCEPT BioRobotics Earnings History

Out of the last 27 earnings reporting periods, PROCEPT BioRobotics beat analysts’ expectations 10 times and fell short of expectations 11 time(s). PROCEPT BioRobotics reported earnings per share of -$ 0.46 in the last report falling to reach an estimated EPS of -$ 0.39 by 17.49%.

Report Date Forecasted EPS Reported EPS Last Year's EPS EPS YoY Change
Nov 4, 2026 -$ 0.39 -$ 0.46 -$ 0.38 -21.05%
Aug 4, 2026 -$ 0.46 -$ 0.47 -$ 0.35 -34.29%
Apr 29, 2026 -$ 0.55 -$ 0.56 -$ 0.45 -24.44%
Feb 25, 2026 -$ 0.32 -$ 0.53 -$ 0.35 -51.43%
Nov 4, 2025 -$ 0.41 -$ 0.38 -$ 0.40 5.00%
Aug 6, 2025 -$ 0.41 -$ 0.35 -$ 0.50 30.00%
Apr 24, 2025 -$ 0.49 -$ 0.45 -$ 0.51 11.76%
Feb 25, 2025 -$ 0.34 -$ 0.35 -$ 0.54 35.19%
Oct 28, 2024 -$ 0.48 -$ 0.40 -$ 0.51 21.57%
Aug 1, 2024 -$ 0.52 -$ 0.50 -$ 0.56 10.71%
May 1, 2024 -$ 0.55 -$ 0.51 -$ 0.63 19.05%
Feb 27, 2024 -$ 0.44 -$ 0.54 -$ 0.56 3.57%
Nov 1, 2023 -$ 0.53 -$ 0.51 -$ 0.51 0.00%
Jul 27, 2023 -$ 0.57 -$ 0.56 -$ 0.43 -30.23%
Apr 27, 2023 -$ 0.59 -$ 0.63 -$ 0.39 -61.54%
Feb 28, 2023 -$ 0.53 -$ 0.56 -$ 0.42 -33.33%
Nov 3, 2022 -$ 0.47 -$ 0.51 -$ 1.22 58.20%
Aug 4, 2022 -$ 0.49 -$ 0.43 -$ 0.36 -17.84%
May 5, 2022 -$ 0.47 -$ 0.39 -$ 0.35 -10.24%
Mar 8, 2022 -$ 0.38 -$ 0.42 -$ 0.43 3.40%

PRCT Earnings-Related Price Changes

PROCEPT BioRobotics’s stock was trading at $ 20.17 on Nov 3, 2026 a day before the last earnings report was released.Following the release of the earnings report, PRCT’s price increased to $ 20.27 on Nov 5, 2026, recording a 0.50% price change in the 48-hour period.

Report Date EPS Price 1 Day Before Price 1 Day After Change
Nov 4, 2026 -$ 0.46 (17.49%)$ 20.17$ 20.270.50%
Aug 4, 2026 -$ 0.47 (1.76%)$ 18.38$ 19.345.22%
Apr 29, 2026 -$ 0.56 (1.82%)$ 23.03$ 24.044.39%
Feb 25, 2026 -$ 0.53 (65.63%)$ 27.26$ 23.63-13.32%
Nov 4, 2025 -$ 0.38 (-7.32%)$ 34.51$ 31.61-8.40%
Aug 6, 2025 -$ 0.35 (-14.63%)$ 48.12$ 39.59-17.73%
Apr 24, 2025 -$ 0.45 (-8.16%)$ 55.70$ 52.49-5.76%
Feb 25, 2025 -$ 0.35 (2.94%)$ 65.15$ 68.114.54%
Oct 28, 2024 -$ 0.40 (-16.67%)$ 68.77$ 96.6940.60%
Aug 1, 2024 -$ 0.50 (-3.85%)$ 63.32$ 57.38-9.38%
May 1, 2024 -$ 0.51 (-7.27%)$ 52.98$ 61.7416.53%
Feb 27, 2024 -$ 0.54 (22.73%)$ 48.84$ 49.391.13%
Nov 1, 2023 -$ 0.51 (-3.77%)$ 26.79$ 32.6121.72%
Jul 27, 2023 -$ 0.56 (-1.75%)$ 37.84$ 35.29-6.73%
Apr 27, 2023 -$ 0.63 (6.78%)$ 35.75$ 30.39-14.99%
Feb 28, 2023 -$ 0.56 (5.66%)$ 37.36$ 37.821.22%
Nov 3, 2022 -$ 0.51 (8.51%)$ 44.21$ 39.85-9.86%
Aug 4, 2022 -$ 0.43 (-12.24%)$ 40.29$ 42.044.34%
May 5, 2022 -$ 0.39 (-17.02%)$ 37.21$ 35.31-5.11%
Mar 8, 2022 -$ 0.42 (10.53%)$ 23.53$ 23.811.19%

FAQs

When does PROCEPT BioRobotics (PRCT) report earnings?

PROCEPT BioRobotics released its most recent earnings reports in November 2026, August 2026, April 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.

What is PROCEPT BioRobotics (PRCT) stock EPS forecast?

PROCEPT BioRobotics missed analysts’ expectations during the last earnings period by 17.49%. PROCEPT BioRobotics reported earnings of -$ 0.46 per share on Nov 4, 2026, while the forecasted EPS was -$ 0.39

Market Closed

PRCT
PROCEPT BioRobotics
$ 23.80
1.23%   Last 24H
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Updated 2 days ago